US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist

29.7700
-0.7400-2.43%

Close Mar 25 16:00 ET

29.9900
+0.2200+0.74%

Pre 04:27 ET

191.57MMarket Cap-0.17P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Total revenue

29.94%10.09M

-31.68%2.58M

-29.26%2.82M

2.21M

2.48M

7.77M

3.78M

3.99M

Operating revenue

29.94%10.09M

-31.68%2.58M

-29.26%2.82M

--2.21M

--2.48M

--7.77M

--3.78M

--3.99M

--0

Cost of revenue

63.78%7.77M

-50.02%1.18M

-34.50%1.56M

3.37M

1.66M

4.74M

2.37M

Gross profit

-23.06%2.33M

-0.92%1.4M

-21.55%1.27M

-1.16M

822K

3.03M

1.41M

1.62M

Operating expense

-36.18%77.48M

-20.14%22.95M

-49.09%15.15M

-40.69%17.2M

-34.60%22.17M

8.31%121.41M

-12.18%28.74M

0.58%29.76M

24.28%29M

28.24%33.9M

Selling and administrative expenses

15.39%40.1M

34.08%15.58M

-11.54%7.71M

6.77%7.5M

25.96%9.31M

15.02%34.75M

44.29%11.62M

17.89%8.71M

3.98%7.03M

-7.77%7.39M

-General and administrative expense

----

6.77%7.5M

25.96%9.31M

----

3.98%7.03M

-7.77%7.39M

Research and development costs

-53.87%39.97M

-51.54%8.3M

-56.70%9.11M

-55.87%9.7M

-51.48%12.86M

5.84%86.66M

-30.62%17.12M

-5.18%21.05M

32.55%21.98M

43.91%26.51M

Other operating expenses

---2.59M

---926K

---1.67M

----

Operating profit

36.52%-75.15M

21.13%-21.55M

50.67%-13.89M

36.70%-18.36M

37.02%-21.35M

-5.61%-118.38M

16.50%-27.33M

4.88%-28.15M

-24.28%-29M

-28.24%-33.9M

Net non-operating interest income expense

Other net income (expense)

-3,287.34%-54.89M

-7,400.00%-511K

-290.12%-327K

-9,452.48%-60.42M

614.83%6.41M

-8.06%1.72M

172K

646K

897K

Gain on sale of security

--6.15M

--0

----

---855K

--7.01M

----

Special income (charges)

---58.96M

--43K

--0

---58.96M

----

--0

----

-Less:Impairment of capital assets

----

--0

--58.96M

----

--0

----

-Write off

--58.96M

----

--0

----

Other non- operating income (expenses)

-220.73%-2.08M

-8,014.29%-554K

-290.12%-327K

-193.65%-605K

-166.11%-593K

-8.06%1.72M

--7K

--172K

--646K

--897K

Income before tax

-11.47%-130.04M

19.24%-22.07M

49.19%-14.21M

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

Income tax

Net income

-11.47%-130.04M

19.08%-22.11M

49.19%-14.21M

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

Net income continuous Operations

-11.47%-130.04M

19.08%-22.11M

49.19%-14.21M

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

Minority interest income

Net income attributable to the parent company

-11.47%-130.04M

19.08%-22.11M

49.19%-14.21M

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-11.47%-130.04M

19.08%-22.11M

49.19%-14.21M

-177.81%-78.78M

54.74%-14.94M

0.19%-116.66M

19.84%-27.32M

3.47%-27.98M

-3.51%-28.36M

-24.94%-33.01M

Basic earnings per share

98.80%-176.6

99.35%-9.77

99.40%-23

60.84%-1.93K

94.39%-576

77.01%-14.72K

86.68%-1.49K

71.53%-3.86K

79.86%-4.92K

66.44%-10.27K

Diluted earnings per share

98.80%-176.6

99.35%-9.77

99.40%-23

60.84%-1.93K

94.39%-576

77.01%-14.72K

86.68%-1.49K

71.53%-3.86K

79.86%-4.92K

66.44%-10.27K

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Total revenue	29.94%10.09M	-31.68%2.58M	-29.26%2.82M	2.21M	2.48M	7.77M	3.78M	3.99M	0	0
Operating revenue	29.94%10.09M	-31.68%2.58M	-29.26%2.82M	--2.21M	--2.48M	--7.77M	--3.78M	--3.99M	--0	--0
Cost of revenue	63.78%7.77M	-50.02%1.18M	-34.50%1.56M	3.37M	1.66M	4.74M	2.37M	2.37M	0	0
Gross profit	-23.06%2.33M	-0.92%1.4M	-21.55%1.27M	-1.16M	822K	3.03M	1.41M	1.62M	0	0
Operating expense	-36.18%77.48M	-20.14%22.95M	-49.09%15.15M	-40.69%17.2M	-34.60%22.17M	8.31%121.41M	-12.18%28.74M	0.58%29.76M	24.28%29M	28.24%33.9M
Selling and administrative expenses	15.39%40.1M	34.08%15.58M	-11.54%7.71M	6.77%7.5M	25.96%9.31M	15.02%34.75M	44.29%11.62M	17.89%8.71M	3.98%7.03M	-7.77%7.39M
-General and administrative expense	----	----	----	6.77%7.5M	25.96%9.31M	----	----	----	3.98%7.03M	-7.77%7.39M
Research and development costs	-53.87%39.97M	-51.54%8.3M	-56.70%9.11M	-55.87%9.7M	-51.48%12.86M	5.84%86.66M	-30.62%17.12M	-5.18%21.05M	32.55%21.98M	43.91%26.51M
Other operating expenses	---2.59M	---926K	---1.67M	----	----	----	----	----	----	----
Operating profit	36.52%-75.15M	21.13%-21.55M	50.67%-13.89M	36.70%-18.36M	37.02%-21.35M	-5.61%-118.38M	16.50%-27.33M	4.88%-28.15M	-24.28%-29M	-28.24%-33.9M
Net non-operating interest income expense
Other net income (expense)	-3,287.34%-54.89M	-7,400.00%-511K	-290.12%-327K	-9,452.48%-60.42M	614.83%6.41M	-8.06%1.72M	7K	172K	646K	897K
Gain on sale of security	--6.15M	--0	----	---855K	--7.01M	----	----	----	----	----
Special income (charges)	---58.96M	--43K	--0	---58.96M	----	--0	--0	--0	--0	----
-Less:Impairment of capital assets	----	----	--0	--58.96M	----	----	----	--0	--0	----
-Write off	--58.96M	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	-220.73%-2.08M	-8,014.29%-554K	-290.12%-327K	-193.65%-605K	-166.11%-593K	-8.06%1.72M	--7K	--172K	--646K	--897K
Income before tax	-11.47%-130.04M	19.24%-22.07M	49.19%-14.21M	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M
Income tax
Net income	-11.47%-130.04M	19.08%-22.11M	49.19%-14.21M	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M
Net income continuous Operations	-11.47%-130.04M	19.08%-22.11M	49.19%-14.21M	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M
Minority interest income
Net income attributable to the parent company	-11.47%-130.04M	19.08%-22.11M	49.19%-14.21M	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-11.47%-130.04M	19.08%-22.11M	49.19%-14.21M	-177.81%-78.78M	54.74%-14.94M	0.19%-116.66M	19.84%-27.32M	3.47%-27.98M	-3.51%-28.36M	-24.94%-33.01M
Basic earnings per share	98.80%-176.6	99.35%-9.77	99.40%-23	60.84%-1.93K	94.39%-576	77.01%-14.72K	86.68%-1.49K	71.53%-3.86K	79.86%-4.92K	66.44%-10.27K
Diluted earnings per share	98.80%-176.6	99.35%-9.77	99.40%-23	60.84%-1.93K	94.39%-576	77.01%-14.72K	86.68%-1.49K	71.53%-3.86K	79.86%-4.92K	66.44%-10.27K
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--